Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Omega-3 – Forschungsarchiv – Seite 42 von 45 | SupStack

Omega-3 – Forschungsarchiv

Studien 3001–3050 von 3153, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

3001RCT1996

Carlson SE, Werkman SH · Lipids (1996)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Omega-3 – Forschungsarchiv

A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months.

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

Fish oil supplementation in patients with heterozygous familial hypercholesterolemia.

Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes.

Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults.

[Polyunsaturated omega-3 fatty acids in the treatment of experimental human gingivitis].

Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions.

Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition.

Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact.

Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease.

Improvement of coronary vasomotion with eicosapentaenoic acid does not inhibit acetylcholine-induced coronary vasospasm in patients with variant angina.

Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed.

Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease.

Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.

Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus.

Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia.

A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians.

Effect of n-3 fatty acid ethyl ester supplementation on fatty acid composition of the single platelet phospholipids and on platelet functions.

Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.

Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio.

Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease.

Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy.

Are long-chain polyunsaturated fatty acids essential nutrients in infancy?

Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.

Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.

Impact of polyunsaturated fatty acids on human colonic bacterial metabolism: an in vitro and in vivo study.

Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation.

Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.

Effects of a low birthweight infant formula containing human milk levels of docosahexaenoic and arachidonic acids.

A randomised double blind placebo controlled trial of fish oil in high risk pregnancy.

The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children.

Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function.

Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.

The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects.

Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids.

A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.

Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues.

Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.

Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.

[Fish oils and rheumatoid arthritis. A randomized and double-blind study].

Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.

Effects of dietary marine oil supplementation on reactivity of human buttock subcutaneous arteries and forearm veins in vitro.

Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases.

[Fish oil supplementation and duration of pregnancy. A randomized controlled trial].

Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study.

Effect of omega 3 fatty acids and vitamin E supplements on lipid peroxidation measured by breath ethane and pentane output: a randomized controlled trial.

Lessons learned from randomizing infants to marine oil-supplemented formulas in nutrition trials.

Long-term effects of n-3 fatty acids on serum lipids and glycaemic control.

Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.

No changes in PAI-1 levels after four-month n-3 PUFA ethyl ester supplementation in healthy subjects.